吃瓜不打烊

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • 吃瓜不打烊 Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Jan 30 2024

Full Issue

Neuralink's First Human Brain Implant Trial Gets Underway

The patient received the first human Neuralink system Sunday and is said to be recovering well. It received FDA permission to begin human trials back in May, and the company began recruiting patients in the fall.

Elon Musk鈥檚 neurotech startup Neuralink implanted its device in a human for the first time on Sunday, and the patient is 鈥渞ecovering well,鈥 the billionaire said in a post on X, formerly known as Twitter, on Monday. The company is developing a brain implant that aims to help patients with severe paralysis control external technologies using only neural signals. (Capoot, 1/29)

Placed in the part of the brain that plans movements, the device is designed to interpret a person鈥檚 neural activity, so they can control external devices such as a smartphone or computer with their thoughts, Neuralink鈥檚 website says. The device is currently in clinical trials, which are open to some individuals who have quadriplegia due to amyotrophic lateral sclerosis (ALS) or a spinal cord injury, according to a recruitment pamphlet. Musk said Monday that the first Neuralink product will be called Telepathy and initially used by people who have lost the ability to use their limbs. 鈥淚magine if Stephen Hawking could communicate faster than a speed typist or auctioneer,鈥 he wrote. 鈥淭hat鈥檚 the goal.鈥 (Ables, 1/30)

Neuralink builds on decades of technology aimed at implanting electrodes in human brains to interpret signals and treat conditions such as paralysis, epilepsy and Parkinson鈥檚 disease. One early device is known as the Utah array, which was first demonstrated in a human in 2004. Many competitors have entered the field, including Synchron and Precision Neuroscience. (McBride, 1/29)

It鈥檚 a potentially significant breakthrough in the field of brain-computer interface technology and the development will also have implications for the tech sector. Musk鈥檚 aim is for people to control smartphones and computers. Big Tech names such as the likes of Apple, Microsoft and others will undoubtedly be monitoring Neuralink鈥檚 progress even if they don鈥檛 plan to get involved in brain-computer interface technology for now. (Keown, 1/30)

In case you missed it 鈥

Elon Musk says no primates died as a result of Neuralink鈥檚 implants. A WIRED investigation now reveals the grisly specifics of their deaths as US authorities have been asked to investigate Musk鈥檚 claims. (Mehrotra and Cameron, 9/20/23)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, July 31
  • Thursday, July 30
  • Wednesday, July 29
  • Tuesday, July 28
  • Monday, July 27
  • Friday, July 24
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • 吃瓜不打烊
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

漏 2026 KFF